Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
J Gastroenterol Hepatol ; 39(2): 360-368, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-37920889

RESUMO

BACKGROUND AND AIM: This study aimed to determine safety and risk factors for adverse events (AEs) of endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) with long-term indwell of lumen-apposing metal stents (LAMS). METHODS: This study is a multicenter prospective observational study on consecutive high surgical-risk patients requiring gallbladder drainage who underwent EUS-GBD with LAMS over 12 months. Centralized telephone follow-up interviews were conducted every 3 months for 1 year. Patients were censored at LAMS removal, cholecystectomy, or death. AE-free survival was determined using log-rank tests. Cumulative risks were estimated using life-table analysis. RESULTS: Eighty-two patients were included (53.7% male, median [interquartile range] age of 84.6 [76.5-89.8] years, and 85.4% with acute cholecystitis). Technical success was achieved in 79 (96.3%), and clinical success in 73 (89%). No patient was lost to follow-up; 45 patients (54.9%) completed 1-year follow-up with in situ LAMS. Median (interquartile range) LAMS indwell time was 364 (47-367) days. Overall, 12 (14.6%) patients presented 14 AEs, including 5 (6.1%) recurrent biliary events (3 acute cholangitis, 1 mild acute pancreatitis, and 1 acute cholecystitis). Patients with pancreatobiliary malignancy had an increased risk of recurrent biliary events (33% vs 1.5%, P = 0.001). The overall 1-year cumulative risk of recurrent biliary events was 9.7% (4.1-21.8%). The 1-year risk of AEs and of severe AEs was 18.8% (11-31.2%) and 7.9% (3.3-18.2%), respectively. Pancreatobiliary malignancy was the single risk factor for recurrent biliary events; LAMS misdeployment was the strongest risk factor for AEs. CONCLUSIONS: Long-term LAMS indwell does not increase the risk of delayed AEs following EUS-GBD.


Assuntos
Colecistite Aguda , Neoplasias , Pancreatite , Humanos , Masculino , Idoso , Idoso de 80 Anos ou mais , Feminino , Doença Aguda , Estudos Prospectivos , Resultado do Tratamento , Pancreatite/epidemiologia , Pancreatite/etiologia , Endossonografia/efeitos adversos , Endossonografia/métodos , Drenagem/efeitos adversos , Drenagem/métodos , Stents , Ultrassonografia de Intervenção , Neoplasias/etiologia
3.
Endoscopy ; 55(7): 591-598, 2023 07.
Artigo em Inglês | MEDLINE | ID: mdl-36882089

RESUMO

BACKGROUND: Removing lumen-apposing metal stents (LAMSs) may be difficult and even harmful, but these features have seldom been analyzed. We aimed to generate a comprehensive assessment of the feasibility and safety of LAMS retrieval procedures. METHODS: A prospective multicenter case series including all technically successfully deployed LAMSs between January 2019 and January 2020 that underwent endoscopic stent removal. All retrieval-related data were prospectively recorded using standardized telephone questionnaires as part of centralized follow-up that ended after stent removal had been performed. Multivariable logistic regression models assessed the potential risk factors for complex removal. RESULTS: For the 407 LAMSs included, removal was attempted in 158 (38.8 %) after an indwell time of 46.5 days (interquartile range [IQR] 31-70). The median (IQR) removal time was 2 (1-4) minutes. Removal was labelled as complex in 13 procedures (8.2 %), although advanced endoscopic maneuvers were required in only two (1.3 %). Complex removal risk factors were stent embedment (relative risk [RR] 5.84, 95 %CI 2.14-15.89; P = 0.001), over-the-wire deployment (RR 4.66, 95 %CI 1.60-13.56; P = 0.01), and longer indwell times (RR 1.14, 95 %CI 1.03-1.27; P = 0.01). Partial and complete embedment were observed in 14 (8.9 %) and five cases (3.2 %), respectively. The embedment rate during the first 6 weeks was 3.1 % (2/65), reaching 15.9 % (10/63) during the following 6 weeks (P = 0.02). The adverse event rate was 5.1 %, including seven gastrointestinal bleeds (5 mild, 2 moderate). CONCLUSIONS: LAMS removal is a safe procedure, mostly requiring basic endoscopic techniques attainable in conventional endoscopy rooms. Referral to advanced endoscopy units should be considered for stents with known embedment or long indwell times, which may require more technically demanding procedures.


Assuntos
Endoscopia Gastrointestinal , Stents , Humanos , Estudos Retrospectivos , Stents/efeitos adversos , Endoscopia Gastrointestinal/efeitos adversos , Fatores de Risco , Drenagem/efeitos adversos , Endossonografia
5.
Rev Esp Enferm Dig ; 114(7): 433-434, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-35170324

RESUMO

We present an otherwise healthy 27 year-old-man who was admitted to our hospital referring acute abdominal pain, diarrhea, rectorrhagia, heavy vomiting, heartburn, dysphagia, high fever and involuntary weight loss of 12 kg in one week. An acute kidney injury, anemia and lymphopenia of 85 CD4 were observed in his blood work. The patient underwent a colonoscopy that was unremarkable. However, the oesophagogastroduodenoscopy (OGD) showed an oesophageal candidiasis in the upper oesophagus along with multiple confluent circumferential ulcerations in its lower 10 cm. Multiple biopsies were taken from the center and the edge of the ulcerations, revealing the presence of inclusion cell bodies.


Assuntos
Síndrome de Imunodeficiência Adquirida , Candidíase , Infecções por Citomegalovirus , Esofagite , Infecções por HIV , Síndrome de Imunodeficiência Adquirida/complicações , Adulto , Candidíase/complicações , Citomegalovirus , Infecções por Citomegalovirus/complicações , Esofagite/complicações , Infecções por HIV/complicações , Humanos , Masculino , Úlcera
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...